Avient Q2 adjusted EPS USD 0.96 vs. IBES estimate USD 0.89

Avient Corporation (NYSE: AVNT) reported second-quarter adjusted earnings per share (EPS) of $0.96, surpassing the IBES estimate of $0.89. The company’s Q2 results reflect continued operational improvements and disciplined cost management, despite mixed demand across its end markets. Avient’s adjusted EPS growth of 5% year-over-year was driven by defense and healthcare segments, which offset weaker demand in consumer markets.

The company’s Q2 sales totaled $866.5 million, representing a 2% increase compared to the prior year quarter, with a favorable impact of 1% from foreign exchange. Avient’s adjusted EBITDA margins expanded by 30 basis points to 17.2%, demonstrating the effectiveness of its productivity initiatives and cost controls.

Looking ahead, Avient has narrowed its full-year adjusted EPS guidance to a range of $2.77 to $2.87, reflecting confidence in its ability to maintain momentum in high-margin markets and continue margin expansion. The company also remains on track to reduce total debt by $100 to $200 million by year-end, supported by strong cash flow from operations.

Avient’s Q2 performance underscores its resilience in navigating macroeconomic uncertainties and aligns with its strategic focus on innovation and customer-centric solutions across its global operations.